nach oben

Reactions Weekly

Erschienen in:

01.06.2018 | Case report

Amantadine

Hallucination: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In a case report, one patient [age and sex not stated] was described, who developed hallucination while receiving amantadine for lower urinary tract symptoms [route, duration of treatment to reaction onset and outcome not stated]. The patient started receiving amantadine 150 mg/day. No side effects were noted. Afterwards, the dose was increased to 300 mg/day. Subsequently, the patient developed hallucination. …

Uchiyama T, et al. Patients with Parkinson's disease and vascular Parkinsonism have lower urinary tract dysfunction and nocturnal polyuria, which can be ameliorated by amantadine. Movement Disorders 31 (Suppl. 1): S22-S23, Mar 2016 [abstract] - Japan

Titel: Amantadine
Hallucination: case report
Publikationsdatum: 01.06.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-48126-1

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Amantadine

Hallucination: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Alendronic-acid

Ticagrelor/aspirin

Dasatinib

Alteplase

Methadone withdrawal

Flucloxacillin